CS logo
small CS logo
Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia

Barcelona, Spain
Hospital department in Barcelona
Passeig de la Vall d'Hebron, 119, 08035 Barcelona

About Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia


During the past decade, Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia


According to Clinical.Site data, the most researched conditions in "Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia" are "Multiple Sclerosis" (2 trials), "Multiple Sclerosis, Primary Progressive" (2 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Relapsing Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia" in a lesser frequency.

Clinical Trials Intervention Types at Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia


Most popular intervention types in "Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Ocrelizumab" (5 trials), "Placebo" (3 trials), "Antihistamine" (2 trials), "Fenebrutinib" (2 trials) and "Methylprednisolone" (2 trials). Other intervention names were less common.

Clinical Trials Genders at Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia


The vast majority of trials in "Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia" are 6 trials for "All" genders.

Clinical Trials Status at Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia


Currently, there are NaN active trials in "Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hospital Universitari Vall d'Hebron; Servicio de Neumo-Inmunologia, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".